GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal Cancer

Abstract

Colorectal cancer (CRC) is the third most frequently diagnosed cancer worldwide, responsible for over 880 000 deaths each year. Growth/differentiation factor 15 (GDF-15) is reported to be a promising diagnostic and prognostic factor in CRC. It induces pleiotropic effects in tumor cells: proliferation, stemness, invasion and metastasis. Some studies indicate that GDF-15 may stimulate angiogenesis in malignant neoplasms. However, it has not been investigated in CRC yet. The aim of our study was to determine the level of GDF-15 and the concentrations of hypoxia-inducible factor-1α (HIF-1α), VEGF-A and chemokine-like receptor 1 (CMKLR1) in tumor and margin specimens of CRC in relation to histological grade and TNM staging. The study comprised 33 samples of tumor and margin tissues obtained from CRC patients. To assess the concentration of GDF-15, HIF-1α, VEGF-A and CMKLR1, commercially available enzyme-linked immunosorbent assay (ELISA) kits were used. We found significantly increased levels of GDF-15 and CMKLR1 in tumor tissue compared to margin tissue and higher concentrations of HIF-1α and VEGF-A in margin tissue than in tumor tissue. The levels of GDF-15 and HIF-1α were significantly correlated with VEGF-A and CMKLR1 in margin tissue. In CRC, the increased level of GDF-15 might stimulate angiogenesis through upregulation of HIF-1α, VEGF A and CMKLR1 expression. Our study is the first one to reveal the correlation between the levels of GDF-15 and CMKLR1 in CRC. The elevated levels of HIF-1α and VEGF-A in tumor-free margin tissues suggest that noncancer cells in the tumor microenvironment are an important source of proangiogenic factors.

Keywords

colorectal cancer / growth/differentiation factor 15 (GDF-15) / chemokine-like receptor 1 (CMKLR1) / VEGF-A / angiogenesis

References

[1] CaoD, HouM, GuanY, et al.. Expression of HIF-lalpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer, 2009, 9: 432

[2] FangL, LiF, GuC. GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer. Curr Pharm Des, 2019, 25(6): 654-662

[3] MinetE, MichelG, RemacleJ, et al.. Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int J Mol Med, 2000, 5(3): 253-259

[4] TamuraR, TanakaT, AkasakiY, et al.. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications. Med Oncol, 2019, 37(1): 2

[5] KiczmerP, SeńkowskaAP, KulaA, et al.. Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers. Exp Mol Pathol, 2020, 113: 104377

[6] ZhangY, WangX, ZhangM, et al.. GDF15 promotes epithelial-to-mesenchymal transition in colorectal corrected. Artif Cells Nanomed Biotechnol, 2018, 46(sup2): 652-658

[7] McDougallSR, AndersonARA, ChaplainMAJ. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol, 2006, 241(3): 564-589

[8] ModiA, DwivediS, RoyD, et al.. Growth differentiation factor 15 and its role in carcinogenesis: an update. Growth Factors, 2019, 37(3–4): 190-207

[9] ZhengH, WuY, GuoT. Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK-eIF2α Signaling. Biomed Res Int, 2020, 2020: 5958272

[10] LiC, WangJ, KongJ, et al.. GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget, 2016, 7(1): 860-872

[11] WeberCE, KuoPC. The tumor microenvironment. Surg Oncol, 2012, 21(3): 172-177

[12] RajaganeshanR, PrasadR, GuillouPJ, et al.. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases. Eur J Surg Oncol, 2009, 35(12): 1286-1294

[13] SimonettiO, LucariniG, RubiniC, et al.. Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis. Oral Dis, 2013, 19(6): 620-627

[14] OhSY, KwonHC, KimSH, et al.. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer, 2008, 8: 123

[15] ShenW, LiHL, LiuL, et al.. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer. Eur Rev Med Pharmacol Sci, 2017, 21(11): 2596-2603

[16] TakalaH, SaarnioJ, WiikH, et al.. HIF-1α and VEGF are associated with disease progression in esophageal carcinoma. J Surg Res, 2011, 167(1): 41-48

[17] Claesson-WelshL, WelshM. VEGFA and tumour angiogenesis. J Intern Med, 2013, 273(2): 114-127

[18] TakahashiT, YamaguchiS, ChidaK, et al.. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J, 2001, 20(11): 2768-2778

[19] LindauD, GielenP, KroesenM, et al.. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology, 2013, 138(2): 105-115

[20] SeeberA, GunsiliusE, GastlG. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy. Oncol Res Treat, 2018, 41(4): 188-193

[21] BrunoT, ValerioM, CasadeiL, et al.. Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization. J Exp Clin Cancer Res, 2017, 36(1): 32

[22] WuY, JinM, XuH, et al.. Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol, 2010, 2010: 537531

[23] LiC, WangX, CasalI, et al.. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. J Cell Mol Med, 2016, 20(8): 1420-1426

[24] VockaM, LangerD, FrybaV, et al.. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer. Cancer Biomark, 2018, 21(4): 869-874

[25] WangW, QiY, XuQ, et al.. Expression and clinical significance of kisspeptin-1, matrix metalloproteinase-2 and vascular endothelial growth factor in tissue of colon cancer. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2016, 37(3): 415-417